Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Compellis Pharmaceuticals

Compellis Pharmaceuticals
2002 FOUNDED
OOB STATUS
71-80 EMPLOYEES
Out of Business LATEST DEAL TYPE
Description

Developer of therapeutic drugs intended to treat obesity and related disorders. The company's therapeutic drugs block calcium channel that decreases caloric intake by reducing olfactory function, enabling patients to achieve a reduction in food intake, thereby leading to a desired weight reduction and better quality of life.

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 141 PowderHouse Boulevard
  • Suite 1
  • Boston, MA 02144
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Compellis Pharmaceuticals’s full profile, request a free trial.

Compellis Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Apr-2016 Completed Out of Business
1. Early Stage VC Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Compellis Pharmaceuticals Executive Team (1)

Name Title Board
Seat
Contact
Info
Christopher Adams Founder, Chief Executive Officer & President